Detection of an outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glucopeptides in a French hospital

Clinical Microbiology and Infection

Volumn 10, Issue 5, 2004, Pages 459-461

  Mallaval, F Olivier ^a,e   Carricajo, A ^b   Delavenna, F ^a   Recule, C ^c   Fonsale, N ^b   Manquat, G ^d   Raffenot, D ^a   Rogeaux, O ^a   Aubert, G ^b   Tous, J ^a  

^a Medical Oncology Department   (France)

^b Saint Etienne Hospital   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

^d Inter Hospitals Hygiene Unit   (France)

^e SERVICE DE NEUROLOGIE   (France)

Author keywords

Glycopeptide resistance; h GISA; MRSA; Outbreak; Staphylococcus aureus

Indexed keywords

ERYTHROMYCIN; FOSFOMYCIN; FUSIDIC ACID; GENTAMICIN; KANAMYCIN; LINCOMYCIN; OXACILLIN; PEFLOXACIN; PENICILLIN G; POLYPEPTIDE ANTIBIOTIC AGENT; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM COLONY; BACTERIUM ISOLATE; CLINICAL ARTICLE; CLONING; CONTROLLED STUDY; DRUG SCREENING; EPIDEMIC; FRANCE; HOSPITAL INFECTION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SCREENING TEST; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STRAIN DIFFERENCE; STRAIN IDENTIFICATION;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 2642553381     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2004.00878.x     Document Type: Article

References (14)

1. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997; 40: 135-136.
2. Hiramatsu K, Aritaka N, Hanaki H et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997; 350: 1670-1673.
3. Fridkin SK. Vancomycin - intermediate and resistant Staphylococcus aureus: what the infectious disease specialist needs to know. Clin Infect Dis 2001; 32: 108-115.
4. Trakulsomboon S, Danchaivijitr S, Rongrungruang Y et al. First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand. J Clin Microbiol 2001; 39: 591-595.
5. Guerin F, Buu-Hoi A, Mainardi JL et al. Outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a Parisian hospital. J Clin Microbiol 2000; 38: 2985-2988.
6. Centers for Disease Control and Prevention. Staphylococcus aureus with reduced susceptibility to vancomycin - United States. MMWR 1997; 46: 765-766.
7. Chesneau O, Morvan A, El Solh N. Retrospective screening for heterogeneous vancomycin resistance in diverse Staphyloccoccus aureus clones disseminated in French hospitals. J Antimicrob Chemother 2000; 45: 887-890.
8. Howe RA, Wootton M, Walsh TR, Bennett PM, Macgowan AP. Heterogeneous resistance to vancomycin in Staphylococcus aureus. J Antimicrob Chemother 2000; 45: 130-132.
9. Berthelot P, Grattard F, Fascia P et al. Implication of a healthcare worker with chronic skin disease in the transmission of an epidemic strain of methicillin-resistant Staphylococcus aureus in a pediatric intensive care unit. Infect Control Hosp Epidemiol 2003; 24: 299-300.
10. Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-2239.
11. Reverdy ME, Jarraud S, Bobin-Dubreux S et al. Incidence of Staphylococcus aureus with reduced susceptibility to glycopeptides in two French hospitals. Clin Microbiol Infect 2001; 7: 267-272.
12. Carricajo A, Mallaval FO, Fonsale N, Vautrin AC, Aubert G. Recherche des souches de Staphyloccocus aureus de sensibilité diminué aux glycopeptides dans un hôpital universitaire (juin 1999-février 2000). Méd Mal Infect 2001; 31: 683-684.
13. Carricajo A, Fonsale N, Vautrin AC, Aubert G. In-vitro activity of β-lactams against gentamicin-susceptible and gentamicin-resistant Staphylococcus aureus. J Antimicrob Chemother 2000; 46: 856-858.
14. Hubert SK, Mohammed JM, Kridkin SK, Gaynes RP, McGowan JE, Tenover FC. Glycopeptide-intermediate Staphylococcus aureus: evaluation of a novel screening method and results of a survey of selected US hospitals. J Clin Microbiol 1999; 37: 3590-3593.